ALSO NOTED: Centocor files sBLA for Remicade; Aurobindo receives approval for AIDS treatment; and much more...

> The FDA has accepted J&J subsidiary Centocor's filing of a supplemental BLA for the use of Remicade in treating plaque psoriasis. Release

> India-based Aurobindo Pharma has received tentative approval from the FDA for its orally administered AIDS treatment Lamivudine. Report

> In a recent study published in the Lancet, Pfizer's Vfend was shown to be safer and more effective in treating fungal blood infections than two older antifungals combined. Release

> Acuity Pharmaceuticals will initiate phase II trials of its drug Cand5 for wet age-related macular degeneration. It is a genetic condition and a leading cause of adult blindness. The therapy uses RNAi technology. Report

And Finally... Greer and Curalogic have entered a strategic relationship in which Greer will supply materials for Curalogic's allergy treatment research. Release